Targeted Talks podcast

#Science #Fitness #Targeted Talks

20:31

Ari Romero & Cole Delbyck share everything you need to know before diving into the dramatic new hospital series, Pulse . Then onto Season 3 of Love On The Spectrum , where we pick up with favorites from past seasons and some new faces, too. Finally, we get the latest from the high stakes competition series, Million Dollar Secret . Follow Netflix Podcasts for more and read about the titles from today’s episode exclusively on Tudum.com .…

Targeted Talks

maison des série•Feed

Targeted Oncology brings you Targeted Talks, a monthly podcast featuring discussions with academic and community oncologists surrounding advancements in cancer research and best practices for patient management.

70 episodes

Targeted Talks

updated il y a environ 27 jours

maison des série•Feed

70 episodes

#Science #Fitness #Targeted Talks

Semua episod

1
S6 Ep4: BMT CTN 1902 in Myeloma: Key Findings With Garfall 14:48

il y a environ 27 jours14:48

14:48

In this episode of Targeted Talks, Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial (NCT05032820) of idecabtagene vicleucel (ide-cel; Abecma), a study focused on patients with multiple myeloma who had a suboptimal response to first-line therapy, including autologous hematopoietic cell transplant and lenalidomide (Revlimid) maintenance.…

1
S6 Ep3: Exploring Innovations in Lymphoma Treatment With Russler-Germain 27:50

il y a 6 weeks27:50

27:50

David A. Russler-Germain, MD, PhD, physician-scientist at Washington University School of Medicine and Siteman Cancer Center, discusses his path in oncology and the many advancements shaping lymphoma treatment today.

1
S6 Ep2: Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia 8:13

il y a 9 weeks8:13

8:13

In this episode of Targeted Talks, Aditya Bardia, MD, MPH, FASCO, discusses the recent FDA approval of datopotamab deruxtecan for the treatment of patients with unresectable or metastatic hormone receptor-positive, HER2-negative breast cancer who have received prior systemic therapy.

1
S6 Ep1: Juneja Explores AI’s Impact in Early Cancer Detection and Treatment 35:13

il y a 12 weeks35:13

35:13

In this episode of Targeted Talks, Sanjay K. Juneja, MD, hematologist & medical oncologist at Mary Bird Perkins Cancer Center, discusses the exciting advancements of artificial intelligence in 2024, specifically focusing on its transformative impact on early cancer detection.

1
S5 Ep20: How AI Is Revolutionizing Oncology in Diagnosis, Treatment, and Research 16:28

il y a 21 weeks16:28

16:28

In this episode of Targeted Talks, Douglas Flora, MD, LSSBB, FACCC, executive medical director of oncology services at St. Elizabeth Healthcare, discusses the transformative impact of artificial intelligence in oncology.

1
S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander 27:56

il y a 23 weeks27:56

27:56

In this episode of Targeted Talks, Seth Wander, MD, PhD, medical oncologist at Massachusetts General Hospital and assistant professor at Harvard Medical School, discusses the clinical importance of ESR1 mutations in hormone receptor-positive metastatic breast cancer and how these mutations influence treatment approaches.…

1
S5 Ep18: Turning Inspiration Into Innovation: Hazim’s Impact on Oncology 16:20

il y a 25 weeks16:20

16:20

Antonious Hazim, MD, hematology medical oncology fellow at Mayo Clinic, Rochester, Minnesota, shares insights on his journey into oncology, his experiences at the Mayo Clinic, and his ongoing research.

1
S5 Ep17: Kaklamani's Insights on EMERALD Trial and Elacestrant in Advanced Breast Cancer 13:41

il y a 28 weeks13:41

13:41

In this episode of Targeted Talks, Virginia Kaklamani, MD, DSc, professor of medicine in the Division of Hematology-Medical Oncology at The University of Texas Health Science Center San Antonio and the leader of the breast cancer program at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses the background, findings, and implications of the phase 3 EMERALD trial.…

1
S5 Ep16: Foran Goes Beyond the Basics of BPDCN 22:32

il y a 29 weeks22:32

22:32

In this episode of Targeted Talks, James M. Foran, MD, discusses the presentation and diagnosis of blastic plasmacytoid dendritic cell neoplasm.

1
S5 Ep15: Tarantino Covers HER2-Low Breast Cancer and Antibody-Drug Conjugates 30:43

il y a 32 weeks30:43

30:43

In this episode of Emerging Experts, Paolo Tarantino, MD, researcher at the European Institute of Oncology, and clinical research fellow at Dana-Farber Cancer Institute, discusses the latest developments in breast cancer research and treatment, focusing on the evolving understanding of HER2-low breast cancer subtypes and the potential advantages of using antibody-drug conjugates.…

1
S5 Ep14: Breaking New Ground in Synovial Sarcoma: Choy on the FDA Approval of Afami-cel 16:05

il y a 34 weeks16:05

16:05

In this episode of Targeted Talks, Edwin Choy, MD, PhD, discussed the FDA approval of afamitresgene autoleucel for the treatment of patients with advanced synovial sarcoma.

1
S5 Ep13: Cancer Research Across Continents: Fujiwara’s Path From Japan to the US 19:23

il y a 36 weeks19:23

19:23

In this episode of Emerging Experts, Yu Fujiwara, shares his journey from Japan to the United States and his path to becoming a specialist in hematology and oncology.

1
S5 Ep12: Advancing Melanoma Treatment: Hamid on Lifileucel's Role 18:04

il y a 38 weeks18:04

18:04

In this episode of Targeted Talks, Omid Hamid, MD, discusses data supporting the use of lifileucel for the treatment of advanced melanoma.

1
S5 Ep11: Transforming Prostate Cancer Care Through Personalized Medicine 23:58

il y a 40 weeks23:58

23:58

Adam Weiner, MD, discusses his journey toward becoming an oncologist with a focus in urology in this episode of Emerging Experts.

1
S5 Ep10: Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM 20:11

il y a 43 weeks20:11